Table 1 Summary of baseline clinical characteristics
Characteristics | Y-75 (n= 36) | Placebo (n= 36) |
|---|---|---|
Age, years | 57.42 ± 4.09 | 58.69 ± 4.34 |
Female sex, n (%) | 34 (94.44) | 36 (100) |
Weight, kg | 58.39 ± 5.42 | 58.83 ± 7.18 |
Height, cm | 157.56 ± 4.69 | 158.28 ± 4.99 |
Menopause, n (%) | 27 (87.10) | 32 (94.12) |
Medical history, n (%) | Â | Â |
Musculoskeletal and connective disease | 12 33.33) | 15 (41.67) |
Cardiovascular disease | 7 (19.44) | 8 (22.22) |
Metabolism and nutritional disease | 5 (13.89) | 6 (16.67) |
Gastrointestinal disease | 4 (11.11) | 2 (5.56) |
Vital sign | Â | Â |
Systolic BP, mmHg | 109.86 ± 10.72 | 108.89 ± 12.25 |
Diastolic BP, mmHg | 75.69 ± 8.12 | 74.31 ± 9.79 |
Heart rate | 69.78 ± 4.85 | 69.56 ± 6.22 |
WBC (10 9 /L) | 5.68 ± 1.47 | 5.25 ± 1.36 |
Neutrophils (%) | 49.59 ± 11.17 | 49.48 ± 9.29 |
Lymphocytes (%) | 39.63 ± 8.04 | 40.98 ± 8.69 |
Monocytes (%) | 6.86 ± 1.56 | 6.58 ± 1.41 |
Eosinophils (%) | 2.15 ± .55 | 2.46 ± 1.90 |
Basophils (%) | 0.53 ± 0.38 | 0.50 ± 0.28 |